On Wednesday, Health Care REIT, Inc. (NYSE:HCN)’s shares inclined 0.74% to $68.31.
Health Care REIT, Inc. (HCN) declared it has successfully accomplished its offering of $750 million in aggregate principal amount of 4.0% senior unsecured notes due June 1, 2025. The notes were priced at 99.926% of their face amount to yield 4.009%.
The company intends to use the net proceeds from this offering to repay advances under its primary unsecured credit facility and for general corporate purposes, counting investing in health care and seniors housing properties.
Citigroup Global Markets Inc., Jefferies LLC, J.P. Morgan Securities LLC, UBS Securities LLC, Credit Agricole Securities (USA) Inc., Goldman, Sachs & Co., Merrill Lynch, Pierce, Fenner & Smith Incorporated and Morgan Stanley & Co. LLC served as joint book-running managers for the offering.
Health Care REIT, Inc. is an independent equity real estate investment trust. The firm engages in acquiring, planning, developing, managing, repositioning and monetizing of real estate assets. It primarily invests in the real estate markets of the United States. The firm primarily invests in senior living and health care properties.
InterOil Corporation (USA) (NYSE:IOC)’s shares gained 8.16% to $51.04.
InterOil Corporation (USA) (IOC) has resumed drilling at Wahoo with the Wahoo-1 side-track exploration well in Petroleum Prospecting License 474 in the Gulf Province of Papua New Guinea.
Wahoo-1 side-track well is the follow-up to Wahoo-1 which was suspended in July 2014 due to higher-than-predictable pressures.
The Wahoo-1 side-track is a noteworthy step-out from existing gas fields and will test whether the successful trends identified around PRL15 extend 170km to the south-east of Elk Antelope.
InterOil holds a 78.1114% interest in the well and is operator. The remaining 21.8886% interest is held by minority interests. InterOil will keep the market informed of material developments.
InterOil Corporation, an independent oil and gas company, engages in the exploration, appraisal, and development of hydrocarbon structures in Papua New Guinea. Its assets comprise the Elk, Antelope, Raptor, and Bobcat fields comprising exploration licenses covering an area of about 16,000 square kilometers located in the Gulf Province of Papua New Guinea.
At the end of Wednesday’s trade, U.S. Silica Holdings Inc (NYSE:SLCA)‘s shares surged 5.00% to $32.97.
U.S. Silica Holdings Inc (SLCA) released its 2014 Sustainability Report, Intersections, detailing the accomplishments over the past year that contributed to the Company’s success in reaching key targets in safety, environmental protection and community support.
The fifth annual Sustainability Report details how the Company’s sustainability efforts intersect with every facet of its business, counting U.S. Silica’s commitment to community investment, employee safety and environmental stewardship. U.S. Silica reached noteworthy milestones in 2014, cementing its status as an industry leader while paving the way for continued innovation and success.
U.S. Silica Holdings, Inc. produces and sells commercial silica in the United States. It operates through two segments, Oil & Gas Proppants, and Industrial & Specialty Products. The company offers whole grain commercial silica products to be used as fracturing sand in connection with oil and natural gas recovery, in addition to sells its whole grain silica products in various size distributions, grain shapes, and chemical purity levels for manufacturing glass products.
Qiagen NV (NASDAQ:QGEN), ended its Wednesday’s trading session with 3.61% gain, and closed at $24.97.
Qiagen NV (QGEN) declared the commercial launch of Inova Genomes, a unique compendium of ethnically, phenotypic ally, and ancestrally diverse whole-genome sequencing data for researchers seeking to accelerate cohort analysis programs or improve success rates in diagnostic odyssey cases. QIAGEN will serve as the exclusive distributor of the database, which is accessible via the company’s secure and integrated Ingenuity® Variant Analysis and CLC Biomedical Genomics Workbench platforms.
The Inova Genomes dataset was built by ITMI from a collection of more than 7,000 whole genomes derived from over 2,800 families who consented to make this information accessible to support advances in disease research. Unlike NIH-funded genomic studies, which must make their data publicly accessible, privately funded studies like those of ITMI do not have this requirement. However, ITMI feels that it has an ethical duty to contribute to collaborative efforts by diverse groups working to better understand human health, and that QIAGEN can offer a unique opportunity to achieve this while stringently protecting participant confidentiality. Using their own bioinformatics tools or QIAGEN’s proprietary bioinformatics tools, researchers can easily and interactively mine these data directly for hypothesis generation and validation, counting in combination with their own data for improved resolution of diagnostic odyssey cases and the reduction of false-positive rates.
QIAGEN N.V. provides sample to insight solutions that transform biological samples into valuable molecular insights worldwide. It offers sample technologies to isolate, purify, and stabilize nucleic acids and proteins in plasmid deoxyribonucleic acid (DNA) purification, ribonucleic acid purification and stabilization, genomic and viral nucleic acid purification, DNA cleanup after polymerase chain reaction (PCR) and sequencing, and library preparation for sequencing applications; and assay technologies to detect molecular targets.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
